Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5449]
News [12654]
Articles [175]
Editorials [5]
Conferences [248]
elearning [17]
Adding elotuzumab to standard treatment for multiple myeloma significantly...
Dr Meletios Dimopoulos - National and Kapodistrian University of Athens, Athens...
Adding elotuzumab to standard treatment for multiple myeloma significantly reduced the risk of disease progression ( Dr Meletios Dimopoulos - National and Kapodistrian University of Athens, Athens, Greece )
12 Jun 2015
Treatment and survival of patients with chronic myeloid leukaemia in Europe
Dr Verena Hoffmann - Ludwig-Maximilians-Universität, München, Germany
Treatment and survival of patients with chronic myeloid leukaemia in Europe ( Dr Verena Hoffmann - Ludwig-Maximilians-Universität, München, Germany )
12 Jun 2015
Expert overview on the recent developments in mantle cell lymphoma
Professor Gordon McVie and Professor Simon Rule
Expert overview on the recent developments in mantle cell lymphoma ( Professor Gordon McVie and Professor Simon Rule )
12 Jun 2015
Round-up of the latest research on lung cancer
Dr James Spicer - Guy's Hospital, London, UK
Round-up of the latest research on lung cancer ( Dr James Spicer - Guy's Hospital, London, UK )
9 Jun 2015
Lenvatinib increases progression free survival when used with everolimus in...
Dr James Larkin - Royal Marsden Hospital, London, UK
Lenvatinib increases progression free survival when used with everolimus in metastatic renal cell carcinoma ( Dr James Larkin - Royal Marsden Hospital, London, UK )
9 Jun 2015
Medically under-represented populations: Refining the calculation of accrual...
Dr Robert Comis - ECOG-ACRIN Cancer Research Group, Philadelphia, USA
Medically under-represented populations: Refining the calculation of accrual targets ( Dr Robert Comis - ECOG-ACRIN Cancer Research Group, Philadelphia, USA )
9 Jun 2015
Enzalutamide preferable to bicalutamide plus LHRH analogue in prostate cancer
Dr Simon Chowdhury - Guy's Hospital, London, UK
Enzalutamide preferable to bicalutamide plus LHRH analogue in prostate cancer ( Dr Simon Chowdhury - Guy's Hospital, London, UK )
9 Jun 2015
Screening to identify unsuitable candidates for ipilimumab in advanced melanoma
Dr Pier Francesco Ferrucci - European Institute of Oncology, Milan, Italy
Screening to identify unsuitable candidates for ipilimumab in advanced melanoma ( Dr Pier Francesco Ferrucci - European Institute of Oncology, Milan, Italy )
9 Jun 2015
Nivolumab alone superior to ipilimumab alone in advanced melanoma
Dr Pier Francesco Ferrucci - European Institute of Oncology, Milan, Italy
Nivolumab alone superior to ipilimumab alone in advanced melanoma ( Dr Pier Francesco Ferrucci - European Institute of Oncology, Milan, Italy )
8 Jun 2015
Extended adjuvant therapy for HER2-positive early breast cancer
Prof Arlene Chan - The Mount Hospital, Perth, Australia
Extended adjuvant therapy for HER2-positive early breast cancer ( Prof Arlene Chan - The Mount Hospital, Perth, Australia )
8 Jun 2015
New dexamethasone combination yields two-fold improvement in median PFS in...
Prof Meletios Dimopoulos - University of Athens, Athens, Greece
New dexamethasone combination yields two-fold improvement in median PFS in multiple myeloma ( Prof Meletios Dimopoulos - University of Athens, Athens, Greece )
5 Jun 2015
Survival benefits following eribulin in advanced liposarcoma and leiomyosarcoma
Dr Patrick Schöffski - University Hospitals Leuven, Leuven, Belgium
Survival benefits following eribulin in advanced liposarcoma and leiomyosarcoma ( Dr Patrick Schöffski - University Hospitals Leuven, Leuven, Belgium )
5 Jun 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation